Cellphire
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9430 Key West Ave, Rockville, Maryland, ...Website
www.cellphire.comRevenue
$9.1 MillionIndustry
About Cellphire
Cellphire Therapeutics is dedicated to saving lives by developing innovative platelet therapeutics aimed at addressing controllable hemorrhage, a leading cause of preventable death. Their products, including the freeze-dried platelet-derived hemostat FPH and Cryopreserved Platelets CPP, are currently in Phase 2 clinical studies and aim to improve hemostatic efficacy for military and civilian patients. The company focuses on ensuring that effective therapies are available to clinicians, particularly in critical situations such as trauma and surgery. With a vision that no one should die from controllable hemorrhage, Cellphire is committed to revolutionizing bleeding treatment through advanced cellular therapies.Explore more
Cellphire Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cellphire
Compare insights from companies similar to Cellphire, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cellphire Tech Stack
A closer look at the technologies used by Cellphire
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellphire
Sign Up For FreeTo access detailed company insights
Cellphire Therapeutics is dedicated to saving lives by developing innovative platelet therapeutics aimed at addressing controllable hemorrhage, a leading cause of preventable death. Their products, including the freeze-dried platelet-derived hemostat FPH and Cryopreserved Platelets CPP, are currently in Phase 2 clinical studies and aim to improve h... Read More
